Douglas S Ingram Sarepta Therapeutics, Inc. (SRPT) insider trading activity

SRPT Quotes by TradingView

Douglas S Ingram is President & CEO of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 390,307 shares of SRPT, which is worth approximately $50.3 Million. The most recent transaction as insider was on Nov 03, 2023, when has been sold 25,225 shares (Common Stock) at a price of $79.97 per share, resulting in proceeds of $2,017,243. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 390K
0% 3M change
6.91% 12M change
Total Value Held $50.3 Million

DOUGLAS S INGRAM Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 03 2023
BUY
Open market or private purchase
$2,017,243 $79.97 p/Share
25,225 Added 6.07%
390,307 Common Stock
Nov 17 2021
BUY
Open market or private purchase
$2,000,579 $79.94 p/Share
25,026 Added 6.42%
365,082 Common Stock
Jun 26 2021
SELL
Payment of exercise price or tax liability
$1,432,085 $80.4 p/Share
17,812 Reduced 4.98%
340,056 Common Stock
Dec 31 2020
SELL
Payment of exercise price or tax liability
$6,332,681 $170.49 p/Share
37,144 Reduced 9.4%
357,868 Common Stock

Also insider at

RLAY
Relay Therapeutics, Inc. Healthcare
DSI

Douglas S Ingram

President & CEO
Cambridge, MA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRPT